Small-Cap Treasure Hunt (UPXI, SVRE, SYRA, TURB, NKGN)

Welcome to a thrilling journey in the world of penny stocks! In this watchlist, we embark on a treasure hunt, seeking out those hidden gems among small-cap stocks. These investments may be modest in size, but they carry the potential for significant growth and remarkable returns. Let's dive into companies that might be undervalued worth exploring.

--

SaverOne 2014 Ltd. (NASDAQ: SVRE) - SaverOne's system is installed in vehicles to address the issue of driver distraction caused by the use of distracting mobile applications while driving, which poses a significant safety risk. The company's main target markets include commercial and private vehicle fleets looking to enhance safety and reduce costs, vehicle manufacturers interested in integrating safety solutions, and insurance and leasing companies. The company has recently affirmed that its operations in Israel remain unaffected by the security situation, despite the recent terrorist attack in the southern part of the country and the Israeli government's declaration of war against the Hamas terrorist organization. SaverOne continues to operate normally and takes measures to ensure the safety of its employees. Their headquarters are situated in the central region of the country, northeast of Tel Aviv, away from border areas. SaverOne's stock price has been trading at a low of under $0.50, and it's worth noting that they have filed an F-3 form that went into effect last month and should be considered when adding this on your watchlist. We will closely monitor this company, considering its small float and stock performance.

--

Upexi, Inc. (NASDAQ: UPXI) - Upexi is a brand owner operating in high-growth markets, including health, wellness, pet, and beauty. Our focus is on driving organic growth for our current brands, particularly in direct-to-consumer and Amazon-scalable segments with strong growth projections. This month, Upexi announced the exclusive launch of the Disney Frozen Castle by its children's toy brand, Tytan Tiles, in collaboration with The Walt Disney Company. The company's President, Nick Romano, praised the team's efforts and innovation in the Magnetic Tile space, anticipating further Disney product launches over the next year. The company's stock has recently experienced a low trading point just above $1. We will closely monitor this stock for any signs of increased trading volume and upward momentum.

--

Syra Health Corp. (NASDAQ: SYRA) - Syra Health is a healthcare company dedicated to enhancing healthcare through innovative services and technology solutions. Their focus is on collaborating with government, payers, providers, life sciences organizations, and academic institutions. Their product and service offerings encompass digital health, behavioral and mental health, population health management, health education, and healthcare workforce solutions. In recent news, Syra Health announced a strategic partnership to expand mental and behavioral health services in educational institutions, such as universities, colleges, and K-12 school districts across the country. Their innovative mental health product, Syrenity, will extend these crucial services to over 6,000 member institutions through E&I. This partnership underscores the shared commitment to addressing the pressing need for accessible and effective mental health support in education. The company has also introduced Syrenity, a proactive mental health product that identifies and integrates telehealth for mental health treatment and services. With the stock trading just below $1.50 and a smaller float, we will closely monitor it for potential consolidation and upward movement.

--

Turbo Energy S.A (NASDAQ: TURB) - Turbo Energy, based in Valencia, Spain, is a pioneering photovoltaic energy storage technology company, focused on innovative solutions that enable consumers to maximize solar energy benefits and reduce electricity costs. By harnessing the power of Artificial Intelligence and advanced technology, Turbo Energy is driving progress toward a more sustainable and energy-efficient future. This month, the company achieved a significant milestone by securing a patent in Spain for its software development, elevating its product, SUNBOX, to the forefront of innovative residential photovoltaic equipment. SUNBOX stands out by offering a comprehensive smart management experience for home solar installations, combining AI-powered algorithms with an electric vehicle charger in a single system. Turbo Energy believes that no other leading company offers such an advanced, savings-focused solution. SUNBOX's AI analyzes electricity consumption and solar panel performance, while its cloud platform provides real-time weather and electricity price forecasts. This forecasting capability optimizes energy use and electric vehicle charging costs. While the patent currently covers Spain, Turbo Energy anticipates international approval by the year's end. This innovation positions Turbo Energy for a leading role in the global energy storage industry, aligning with the quest for a more sustainable future. With a smaller float and trading just above $1 at its lows, we will closely monitor the stock for any signs of increased trading volume.

--

NKGen Biotech Inc. (NASDAQ: NKGN) - NKGen Biotech, located in Santa Ana, California, is a leading developer of innovative natural killer cell therapies, including autologous, allogeneic, and CAR-NK options. This month, the company received FDA approval for its Investigational New Drug (IND) application, advancing the SNK01 program targeting Alzheimer's Disease. The Phase 1/2a clinical trial for moderate Alzheimer's Disease is set to commence by the end of 2023, with promising results showcased in presentations at the Alzheimer's Association International Conference and the World Congress of Neurology. These results demonstrate SNK01's safety and efficacy in crossing the blood-brain barrier, reducing neuroinflammation-related proteins without causing adverse effects. Additionally, NKGen presented Phase I trial data on its investigational NK cell therapy, SNK01, for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Annual Meeting in Boston. This remarkable progress is based on collaborations and clinical research, and we will closely monitor the stock's performance. Despite a recent drop to around $3.50 after popping to highs, there could be a potential for a rebound. Notably, the company has also filed an S-1 this month so something to also take into consideration when factoring this company into your watchlist.

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTime Penny is not a fiduciary by virtue of any person's use of or access to this content.